Microchipping firm Identicare sold to British investor

The international animal health business says it decided to sell its majority stake in the microchipping entity to focus on pharmaceuticals and drive growth through new product launches. 

Jenny Winter, CEO of Animalcare, states the sale is a “logical next step” that “significantly” boosts the company’s balance sheet and gives it additional “financial flexibility” to implement its strategy. 

Commenting on the deal, Identicare Co-Owner and CEO Robert Diamond notes, “We are committed to rapidly growing our promise to pet keepers, both in the UK and hopefully overseas.” 

Diamond adds that with the backing of a strong financial partner, the company “will grow the team across all areas of microchipping, registration services and real-time support for keepers whose pets sadly go missing.”

Operating an independent business

Following the completion of this transaction, Identicare says it will now operate as an independent business. Founded in 1989 by Animalcare, the company claims to operate the UK’s largest microchipping, pet protection and keeper registration database. 

In 2021, the company became a separate subsidiary, and in 2022, it signed a development agreement with entrepreneur Robert Diamond to develop a range of pet protection services for UK-based pet owners.